All In Biotech

Drug Trial Radar · NCT00206583

Efficacy and Safety Study of an Oral Contraceptive in Healthy Females

A Multicenter, Open-label Uncontrolled Study to Investigate the Efficacy and Safety of a 4-phasic Oral Contraceptive SH T0065 in a 28-day Regimen for 13 Cycles in Healthy Female Subjects

Last checked: Nov 20, 2026Latest source record: Oct 1, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

499

Actual

Start

Mar 2005

Primary completion

Jun 2007

Study completion Jul 2007

Sponsor

Lead sponsor
BayerBayer (BAYRY)
Sponsor type
Industry
First posted
Sep 21, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Prevention
Who can join
Female only, from 18 years, up to 35 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether the study drug is safe and effective in the prevention of pregnancies in a large group of volunteers.

Conditions

  • Contraception

Interventions

  • EV/DNG (Qlaira, BAY86-5027, SH T00658ID)Drug

    GA: Estradiolvalerate (EV)/Dienogest (DNG) Tablet p.o. (oral) Tablet, p.o. (oral)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of unintended pregnancies after 1 yearTime frame: Throughout 1 year of treatment

Locations

29 sites in 2 countries. Site status is shown where the registry gives one.

  • Women and Children's Hospital, Los Angeles

    Los Angeles, California

  • Lifespan Research

    Palo Alto, California

  • Genesis Center for Clinical Research

    San Diego, California

  • Medical Center for Clinical Research

    San Diego, California

  • Harbor - UCLA Medical Center

    Torrance, California

  • Clinical Trial Center of Colorado

    Castle Rock, Colorado

  • New Age Medical Research Corp.

    Miami, Florida

  • Visions Clinical Research

    Palm Springs, Florida

  • Insignia Care for Women, P.A.

    Tampa, Florida

  • Comprehensive Clinical Trials

    West Palm Beach, Florida

  • Physicians Research Group

    Indianapolis, Indiana

  • Johns Hopkins Bayview Medical Center

    Baltimore, Maryland

  • Women's Clinic of Lincoln, PC

    Lincoln, Nebraska

  • Women's Care Source

    Morristown, New Jersey

  • OB/GYN Health Center

    Medford, Oregon

  • Oregon Health and Science University

    Portland, Oregon

  • Clinical Research of Philadelphia, LLC

    Philadelphia, Pennsylvania

  • University of Pittsburgh Medical Center Health System

    Pittsburgh, Pennsylvania

  • Eastern Virginia Medical School

    Norfolk, Virginia

  • Seattle Women's: Health, Research, Gynecology

    Seattle, Washington

  • Total Concept Health Care Inc.

    Kitchener, Ontario, Canada

  • Temple Green Clinic

    Waterloo, Ontario, Canada

  • Rhodin Recherche Clinique

    Drummondville, Quebec, Canada

  • Centre d'étude clinique de Montréal Inc.

    Montreal, Quebec, Canada

  • Les Gynecologues Associes

    Montreal, Quebec, Canada

  • Clinique Recherche en Sante des Femmes Inc.

    Québec, Quebec, Canada

  • Clinique de Gynecologie

    Shawinigan, Quebec, Canada

  • Diex Recherche Inc.

    Sherbrooke, Quebec, Canada

  • Clinique Médicale des Campus

    Ste-Foy, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.